Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$1.09B |
| 3 |
Wells Fargo
WFC
|
+$651M |
| 4 |
ConocoPhillips
COP
|
+$595M |
| 5 |
UnitedHealth
UNH
|
+$509M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
KKR & Co
KKR
|
+$937M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 4 |
CRH
CRH
|
+$630M |
| 5 |
Meta Platforms (Facebook)
META
|
+$615M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Healthcare | 14.24% |
| 3 | Financials | 12.05% |
| 4 | Industrials | 11.02% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMTX
3651
DELISTED
BM Technologies, Inc.
BMTX
| $53.1K | ﹤0.01% |
+23,584
| New | +$53.1K |
|
3652
Modular Medical
MODD
$45.9M
| $52.6K | ﹤0.01% |
+33,311
| New | +$52.6K |
|
|
CBIO
3653
Crescent Biopharma, Inc. Common Stock
CBIO
$180M
| $52.4K | ﹤0.01% |
1,862
-5,608
| -75% | -$158K |
|
3654
Immix Biopharma
IMMX
$62M
| $52.1K | ﹤0.01% |
26,300
-27,981
| -52% | -$55.4K |
|
3655
Accuray
ARAY
$184M
| $51.9K | ﹤0.01% |
28,502
-21,306
| -43% | -$38.8K |
|
|
ICAD
3656
DELISTED
iCAD Inc
ICAD
| $51K | ﹤0.01% |
39,264
-11,377
| -22% | -$14.8K |
|
3657
The Oncology Institute
TOI
$282M
| $50.2K | ﹤0.01% |
109,207
-39,057
| -26% | -$18K |
|
3658
Oramed Pharmaceuticals
ORMP
$97.6M
| $50K | ﹤0.01% |
+19,457
| New | +$50K |
|
3659
GrowGeneration
GRWG
$100M
| $49.6K | ﹤0.01% |
23,056
-176,830
| -88% | -$380K |
|
3660
Beyond Air
XAIR
$12.6M
| $47.9K | ﹤0.01% |
+4,460
| New | +$47.9K |
|
3661
LAVA Therapeutics
LVTX
$40.8M
| $47.7K | ﹤0.01% |
26,493
+6,465
| +32% | +$11.6K |
|
3662
Lantern Pharma
LTRN
$41.8M
| $47.3K | ﹤0.01% |
+10,135
| New | +$47.3K |
|
|
TBIO
3663
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $47.1K | ﹤0.01% |
12,911
| – | – |
|
|
ILLR
3664
Triller Group Inc. Common Stock
ILLR
$108M
| $47K | ﹤0.01% |
+7,442
| New | +$47K |
|
3665
Akebia Therapeutics
AKBA
$780M
| $46.6K | ﹤0.01% |
45,685
-3,220,315
| -99% | -$3.28M |
|
3666
Heritage Global
HGBL
$65.7M
| $46.2K | ﹤0.01% |
18,769
-23,637
| -56% | -$58.1K |
|
3667
Riverview Bancorp
RVSB
$103M
| $45.9K | ﹤0.01% |
+11,514
| New | +$45.9K |
|
|
ASM
3668
Avino Silver & Gold Mines
ASM
$640M
| $45.8K | ﹤0.01% |
+50,930
| New | +$45.8K |
|
3669
Mawson Infrastructure Group
MIGI
$8.54M
| $45.5K | ﹤0.01% |
+31,847
| New | +$45.5K |
|
|
NNDM
3670
Nano Dimension
NNDM
$313M
| $44.9K | ﹤0.01% |
20,395
-98,380
| -83% | -$216K |
|
3671
One Stop Systems
OSS
$123M
| $42.1K | ﹤0.01% |
+17,464
| New | +$42.1K |
|
|
NB
3672
NioCorp Developments
NB
$382M
| $41.4K | ﹤0.01% |
+23,912
| New | +$41.4K |
|
|
SOS
3673
SOS Limited
SOS
$16.3M
| $41.2K | ﹤0.01% |
3,275
+725
| +28% | +$9.12K |
|
3674
Xtant Medical Holdings
XTNT
$79M
| $39.5K | ﹤0.01% |
62,682
-175,923
| -74% | -$111K |
|
3675
Rapid Micro Biosystems
RPID
$131M
| $38.9K | ﹤0.01% |
58,989
-7,198
| -11% | -$4.75K |
|